Evolution of toxicological science: The need for change

International Journal of Risk Assessment and Management

Volumn 20, Issue 1, 2017, Pages 21-45

  Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

High throughput; Mixtures; Precautionary approach; Susceptible populations; Toxicity testing

Indexed keywords

EID: 85014835818     PISSN: 14668297     EISSN: 17415241     Source Type: Journal    
DOI: 10.1504/IJRAM.2017.082570     Document Type: Article

References (121)

1. Altman, D.G. (1994) 'The scandal of poor medical research', BMJ: British Medical Journal, Vol. 308, No. 6924, pp.283-284.
2. Altman, D.G. (1998) 'Statistical reviewing for medical journals', Statistics in Medicine, Vol. 17, No. 23, pp.2661-2674.
3. Altman, D.G. (2002) 'Poor-quality medical research - what can journals do?', JAMA: The Journal of the American Medical Association, Vol. 287, No. 21, pp.2765-2767.
4. Ames, B.N. and Gold, L.S. (2000) 'Paracelsus to parascience: the environmental cancer distraction', Mutat. Res., Vol. 447, No. 1, pp.3-13.
5. Andersen, B. (1990) Methodological errors in medical research: An Incomplete Catalogue, 288pp, Blackwell Science Ltd., Chicago.
6. Andersen, M.E., Clewell III, H.J., Carmichael, P.L. and Boekelheide, A.K. (2011) 'Can case study approaches speed implementation of the NRC report: 'Toxicity Testing in the 21st Century: A Vision and a Strategy?'', ALTEX, Vol. 28, No. 3, pp.1-8.
7. Arrowsmith, J.J. (2012) 'A decade of change', Nature Reviews Drug Discovery, Vol. 11, No. 1, pp.17-18.
8. Baker, D.D., Lidster, K.K., Sottomayor, A.A. and Amor, S.S. (2012) 'Reproducibility: research-reporting standards fall short', Nature, Vol. 492, No. 7427, pp.41-41.
9. Ball, N., Cronin, M.T.D., Shen, J., Blackburn, K., Booth, E.D., Bouhifd, M., Donley, E., Egnash, L., Hastings, C., Juberg, D.R., Kleensang, A., Kleinstreuer, N., Kroese, D., Lee, A.C., Luechtefeld, T., Maertens, A., Marty, S., Naciff, J.M., Palmer, J., Pamies, D., Penman, M., Richarz, A-N., Russo, D.P., Stuard, S.B., Patlewicz, G., van Ravenzwaay, B., Wu, S., Zhu, H., and Hartung, T. (2016) 'Toward good read-across practice (GRAP) guidance', ALTEX, Vol. 33, No. 2, pp.149-166 [online] http://doi.org/10.14573/altex.1601251.
10. Basketter, D.A., Clewell, H. and Kimber, I. et al. (2012) 'A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report', ALTEX, Vol. 29, No. 1, pp.3-91.
11. Bebarta, V., Luyten, D. and Heard, K. (2003) 'Emergency medicine animal research: does use of randomization and blinding affect the results?', Academic Emergency Medicine, Vol. 10, No. 6, pp.684-687.
12. Begley, C.G. and Ellis, L.M. (2012) 'Drug development: raise standards for preclinical cancer research', Nature, Vol. 483, No. 7391, pp.531-533.
13. Bottini, A.A. and Hartung, T. (2009) 'Food for thought... on the economics of animal testing', ALTEX, Vol. 26, No. 1, pp.3-16.
14. Bottini, A.A. and Hartung, T. (2010) 'The economics of animal testing', ALTEX, Special Issue, Vol. 27, No. 1, pp.67-77.
15. Bottini, A.A., Amcoff, P. and Hartung, T. (2007) 'Food for thought ... on globalisation of alternative methods', ALTEX, Vol. 24, No. 4, pp.255-269.
16. Bouhifd, M., Andersen, M.E., Baghdikian, C., Boekelheide, K., Crofton, K.M., Fornace Jr., A.J., Kleensang, A., Li, H., Livi, C.B., Maertens, A., McMullen, P.D., Rosenberg, M., Thomas, R., Vantangoli, M., Yager, J.D., Zhao, L. and Hartung, T. (2015) 'The Human Toxome project', ALTEX 2015, Vol. 32, pp.112-124.
17. Briel, M., Müller, K.F. and Meerpohl, J.J. et al. (2013) 'Publication bias in animal research: a systematic review protocol', Systematic Reviews, Vol. 2, pp.23-23.
18. Bruchmüller, I., Pirkl, E. and Herrmann, R. et al. (2006) 'Introduction of a validation concept for a PCR-based Mycoplasma detection assay', Cytotherapy, Vol. 8, No. 1, pp.62-69.
19. Buehring, G.C., Eby, E.A. and Eby, M.J. (2004) 'Cell line cross-contamination: how aware are mammalian cell culturists of the problem and how to monitor it?', In Vitro Cellular & Developmental Biology - Animal, Vol. 40, No. 7, pp.211-215.
20. Coecke, S., Balls, M. and Bowe, G. et al. (2005) Guidance on Good Cell Culture Practice, Vol. 33, pp.261-287, a report of the second ECVAM task force on good cell culture Practice, Alternatives to Laboratory Animals - ATLA.
21. Dabrazhynetskaya, A.A., Volokhov, D.V.D. and David, S.W.S. et al. (2011) 'Preparation of reference strains for validation and comparison of mycoplasma testing methods', Journal of Applied Microbiology, Vol. 111, No. 4, pp.904-914.
22. Dietrich, D.R. (2010) 'Courage for simplification and imperfection in the 21st century assessment of 'Endocrine disruption', ALTEX, Vol. 27, No. 4, pp.264-278.
23. DiMasi, J.A. and Grabowski, H.G. (2007) 'The cost of biopharmaceutical R&D: is biotech different?', Manage. Decis. Econ., Vol. 28, Nos. 4-5, pp.469-479.
24. Dirks, W.G., Macleod, R.A.F. and Nakamura, Y. et al. (2010) 'Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines', International Journal of Cancer, Vol. 126, No. 1, pp.303-304.
25. Drexler, H.G. and Uphoff, C.C. (2002) 'Mycoplasma contamination of cell cultures: incidence, sources, effects, detection, elimination, prevention', Cytotechnology, Vol. 39, No. 2, pp.75-90.
26. EFSA GMO Panel Working Group on Animal Feeding Trials (2008) 'Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials', Food Chem. Toxicol., Vol. 46, No. Suppl. 1, pp.S2-S70.
27. Fang, F.C., Steen, R.G. and Casadevall, A. (2012) 'Misconduct accounts for the majority of retracted scientific publications', Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, No. 42, pp.17028-17033.
28. Festing, M. (2003) 'Principles: the need for better experimental design', Trends in Pharmacological Sciences, Vol. 27, No. 7, pp.341-345.
29. Gilbert, J., Henske, P. and Singh, A. (2003) 'Rebuilding big pharma's business model, in vivo, the business & medicine report', Windhover Information, Vol. 21, No. 10 [online] https://www.ucl.ac.uk/wibr/teaching/Docs/rebuilding-big-pharma.pdf.
30. Gocht, T., Berggren, E., Ahr, H.J. et al. (2015) 'The SEURAT-1 approach towards animal free human safety assessment', ALTEX, Vol. 32, No. 1, pp.9-24.
31. Gold, L.S., Manley, N.B. and Slone, T.H. et al. (2005) 'Supplement to the carcinogenic potency database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998', Toxicol. Sci., Vol. 85, No. 2, pp.747-808.
32. Hackam, D.G. (2007) 'Translating animal research into clinical benefit', BMJ: British Medical Journal, Vol. 334, No. 7586, pp.163-164.
33. Hackam, D.G. and Redelmeier, D.A. (2006) 'Translation of research evidence from animals to humans', JAMA: the Journal of the American Medical Association, Vol. 296, No. 14, pp.1731-1732.
34. Hartung, T. (2007a) 'Food for thought ... on cell culture', ALTEX, Vol. 24, No. 3, pp.143-152.
35. Hartung, T. (2007b) 'Food for thought on validation', ALTEX, Vol. 24, No. 2, pp.67-72.
36. Hartung, T. (2008a) 'Food for thought ... on alternative methods for cosmetics safety testing', ALTEX, Vol. 25, No. 3, pp.147-162.
37. Hartung, T. (2008b) 'Food for thought ... on animal tests', ALTEX, Vol. 25, No. 3, pp.3-16.
38. Hartung, T. (2008c) 'Toward a new toxicology - evolution or revolution?', ATLA - Alternatives to Laboratory Animals, Vol. 36, No. 6, pp.635-639.
39. Hartung, T. (2009a) 'Food for thought ... on evidence-based toxicology', ALTEX, Vol. 26, No. 2, pp.75-82.
40. Hartung, T. (2009b) 'Toxicology for the twenty-first century', Nature, Vol. 460, No. 7252, pp.208-212.
41. Hartung, T. (2009c) 'Per aspirin ad astra...', Alternatives to Laboratory Animals: ATLA, Vol. 37, No. Suppl. 2, pp.45-47.
42. Hartung, T. (2010a) 'Comparative analysis of the revised Directive 2010/63/EU for the protection of laboratory animals with its predecessor 86/609/EEC - a t4 report', ALTEX, Vol. 27, No. 4, pp.285-303.
43. Hartung, T. (2010b) 'Evidence-based toxicology - the toolbox of validation for the 21st century?', ALTEX, Vol. 27, No. 4, pp.253-263.
44. Hartung, T. (2010c) 'Food for thought ... on alternative methods for nanoparticle safety testing', ALTEX, Vol. 27, No. 2, pp.87-95.
45. Hartung, T. (2010d) 'Food for thought ... on alternative methods for chemical safety testing', ALTEX, Vol. 27, No. 1, pp.3-14.
46. Hartung, T. (2010e) 'Lessons learned from alternative methods and their validation for a new toxicology in the 21st century', J. Toxicol. Env. Health, Vol. 13, Nos. 2-4, pp.277-290.
47. Hartung, T. (2013) 'Look back in anger - what clinical studies tell us about preclinical work', ALTEX, Vol. 30, No. 3, pp.275-291.
48. Hartung, T. and Corsini, E. (2013) 'Immunotoxicology: challenges in the 21st century and in vitro opportunities', ALTEX, Vol. 30, No. 4, pp.411-426.
49. Hartung, T. and Daston, G. (2009) 'Are in vitro tests suitable for regulatory use?', Tox. Sci., Vol. 111, No. 2, pp.233-237.
50. Hartung, T. and Hoffmann, S. (2009) 'Food for thought ... on in silico methods in toxicology', ALTEX, Vol. 26, No. 3, pp.155-166.
51. Hartung, T. and Koeter, H. (2008) 'Food for thought on alternative methods for food safety testing', ALTEX, Vol. 25, No. 4, pp.259-264.
52. Hartung, T. and McBride, M. (2011) 'Food for thought on mapping the human toxome', ALTEX, Vol. 28, No. 2, pp.83-93.
53. Hartung, T. and Rovida, C. (2009) 'Chemical regulators have overreached', Nature, Vol. 460, No. 7259, pp.1080-1081.
54. Hartung, T. and Sabbioni, E. (2011) 'Alternative in vitro assays in nanomaterial toxicology', Nanomedicine and Nanobiotechnology, Vol. 3, No. 6, pp.545-573, DOI: 10.1002/wnan.153.
55. Hartung, T. and Zurlo, J. (2012) 'Food for thought ... Alternative approaches for medical countermeasures to biological and chemical terrorism and warfare', ALTEX, Vol. 29, No. 3, pp.251-260.
56. Hartung, T., Bremer, S. and Casati, S. et al. (2004) 'A modular approach to the ECVAM principles on test validity', ATLA - Alternatives to Laboratory Animals, Vol. 32, No. 5, pp.467-472.
57. Hartung, T., van Vliet, E. and Jaworska, J. et al. (2012) 'Food for thought ... systems toxicology', ALTEX, Vol. 29, No. 2, pp.119-128.
58. Hay, R.J., Macy, M.L. and Chen, T.R. (1989) 'Mycoplasma infection of cultured cells', Nature, Vol. 339, No. 6224, pp.487-488.
59. Hoffmann, S. and Hartung, T. (2006) 'Toward an evidence-based toxicology', Human and Experimental Toxicology, Vol. 25, Nos. 2-3, pp.497-513.
60. Hoffmann, S., Stephens, M. and Hartung, T. (2014) 'Evidence-based toxicology', in Wexler, P. (Ed.): Encyclopedia of Toxicology, 3rd ed., Vol. 2, pp.565-567, Elsevier Inc., Academic Press.
61. Hooijmans, C.R., Leenaars, M. and Ritskes-Hoitinga, M. (2010) 'A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three Rs, and to make systematic reviews more feasible', ATLA - Alternatives to Laboratory Animals, Vol. 38, No. 2, pp.167-182.
62. Hughes, P., Marshall, D., Reid, Y., Parkes, H. and Gelber, C. (2007) 'The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?', BioTechniques, Vol. 43, No. 5, pp.575-584.
63. Ioannidis, J.P.A. (2005a) 'Contradicted and initially stronger effects in highly cited clinical research', JAMA: The Journal of the American Medical Association, Vol. 294, No. 2, pp.218-226.
64. Ioannidis, J.P.A. (2005b) 'Why most published research findings are false', PLoS Medicine, Vol. 2, No. 8, pp.e124-e124.
65. Janssens, A.C.J.W. and van Duijn, C.M. (2008) 'Genome-based prediction of common diseases: advances and prospects', Human Molecular Genetics, Vol. 17, No. R2, pp.R166-R173.
66. Juberg, D.R., Borghoff, S.J. and Becker, R.A. et al. (2013) 't4 workshop report: lessons learned, challenges, and opportunities: the US endocrine disruptor screening program', ALTEX, Vol. 31, No. 6, pp.63-78.
67. Kilkenny, C.C., Browne, W.J., Cuthill, I.C., Emerson, M. and Altman, D.G. (2010) 'Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research', PLoS Biology, Vol. 8, No. 6, p.e1000412.
68. Kipen, H.M. and Laskin, D.L. (2005) 'Smaller is not always better: nanotechnology yields nanotoxicology', Am. J. Physiol. Lung. Cell. Mol. Physiol., Vol. 289, No. 5, pp.L696-L697.
69. Knight, A. (2007) 'Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility', ATLA - Alternatives to Laboratory Animals, Vol. 35, No. 5, pp.641-659.
70. Knight, J. and Rovida, C (2014) 'Safety evaluations under the proposed US Safe Cosmetics and Personal Care Products Act of 2013: animal use and cost estimates', ALTEX, Vol. 31, No. 2, pp.177-208.
71. Landry, J.J.M., Pyl, P.T. and Rausch, T. et al. (2013) 'The genomic and transcriptomic landscape of a HeLa cell line', G3 Genes-Genomes-Genetics Early Online, published on 11 March, DOI: 10.1534/g3.113.005777.
72. Lang, T. (2004) 'Twenty statistical errors even you can find in biomedical research articles', Croatian Medical Journal, Vol. 45, No. 4, pp.361-370.
73. Langdon, S.P. (2003) 'Cell culture contamination: an overview', in Langdon, S.P. (Ed.): Methods in Molecular Medicine, Cancer Cell Culture: Methods and Protocols Cancer Cell Culture, Vol. 88, pp.309-318, Humana Press, Totowa, New Jersey.
74. Lawrence, B., Bashiri, H. and Dehghani, H. (2010) 'Cross comparison of rapid mycoplasma detection platforms', Biologicals, Vol. 38, No. 2, pp.6-6.
75. Leist, M. and Hartung, T. (2013) 'Reprint: inflammatory findings on species extrapolations: humans are definitely no 70-kg mice', ALTEX, Vol. 30, No. 2, pp.227-230.
76. Leist, M., Efremova, L. and Karreman, C. (2010) 'Food for thought ... considerations and guidelines for basic test method descriptions in toxicology', ALTEX, Vol. 27, No. 4, pp.309-317.
77. Leist, M., Hasiwa, M., Daneshian, M. and Hartung, T. (2012) 'Validation and quality control of replacement alternatives - current status and future challenges', Toxicological Research, Vol. 1, pp.8-22, DOI: 10.1039/C2TX20011B.
78. Leist, M., Hasiwa, N., Rovida, C. et al. (2014) 'Consensus report on the future of animal-free systemic toxicity testing', ALTEX, Vol. 31, No. 3, pp.341-356.
79. Luechtefeld, T., Maertens, A., Russo, D.P., Rovida, C., Zhu, H. and Hartung, T. (2016) 'Global analysis of publicly available safety data for 9, 801 substances registered under REACH from 2008-2014', ALTEX, Vol. 33, No. 2, pp.95-109 [online] http://doi.org/10.14573/altex.1510052.
80. Lumbreras, B., Parker, L.A., Porta, M., Pollan, M., Ioannidis, J.P.A. and Hernandez-Aguado, I. (2009) 'Overinterpretation of clinical applicability in molecular diagnostic research', Clinical Chemistry, Vol. 55, No. 4, pp.786-794.
81. Lund, R.J., Närvä, E. and Lahesmaa, R. (2012) 'Genetic and epigenetic stability of human pluripotent stem cells', Nature Reviews Genetics, Vol. 13, No. 10, pp.732-744.
82. MacCallum, C.J. (2010) 'Reporting animal studies: good science and a duty of care', PLoS Biol., Vol. 8, p.e1000413, DOI: 10.1371/journal.pbio.1000413.
83. Macleod, M. and van der Worp, H.B. (2010) 'Animal models of neurological disease: are there any babies in the bathwater?', Practical Neurolology, Vol. 10, No. 6, pp.312-314.
84. Macleod, R.A.F., Dirks, W.G., Matsuo, M., Kaufmann, Y., Milch, H. and Drexler, H.G. (1999) 'Widespread intraspecies cross-contamination of human tumor cell lines arising at source', International Journal of Cancer, Vol. 83, No. 4, pp.555-563.
85. Maertens, A., Anastas, N., Spencer, P.J., Stephens, M., Goldberg, A. and Hartung, T. (2014) 'Green toxicology', ALTEX, Vol. 31, No. 3, pp.243-249.
86. Mignini, L.E. and Khan, K.S. (2006) 'Methodological quality of systematic reviews of animal studies: a survey of reviews of basic research', BMC Medical Research Methodology, Vol. 6, p.10, DOI: 10.1186/1471-2288-6-10.
87. Mitalipova, M.M., Rao, R.R. and Hoyer, D.M. et al. (2005) 'Preserving the genetic integrity of human embryonic stem cells', Nature Biotechnology, Vol. 23, No. 1, pp.19-20.
88. Mundae, M.K. and Östor, A.J.K. (2010) 'The long road of biopharmaceutical drug development: from inception to marketing', Q.J. Med., Vol. 103, No. 1, pp.3-7.
89. Neltner, T.G., Alger, H.M. and Leonard, J.E. et al. (2013) 'Data gaps in toxicity testing of chemicals allowed in food in the United States', Reproductive Toxicology, Vol. 42, pp.85-94.
90. Nikfarjam, L. and Farzaneh, P. (2012) 'Prevention and detection of Mycoplasma contamination in cell culture', Cell Journal (Yakhteh), Vol. 13, No. 4, pp.203-212.
91. NRC - National Research Council, Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents (2011) Animal Models for Assessing Countermeasures to Bioterrorism Agents, pp.1-153, the National Academies Press, Washington, DC, USA [online] http://dels.nationalacademies.org/Report/Animal-Models-Assessing-Countermeasures/13233 (accessed 20 April 2016).
92. OECD (2005) Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment, OECD Series on testing and assessment No. 34, pp.1-96.
93. Olson, H., Betton, G. and Robinson, D. et al. (2000) 'Concordance of the toxicity of pharmaceuticals in humans and in animals', Regulatory Toxicology and Pharmacology, Vol. 32, No. 1, pp.56-67.
94. Pajares, F. (n.d.) Outline and Study Guide to the Structure of Scientific Revolutions by Thomas S. Kuhn, Emory University, Atlanta, GA, USA [online] http://www.des.emory.edu/mfp/Kuhn.html (accessed 15 October 2008).
95. Patlewicz, G., Ball, N., Becker, R.A., Blackburn, K., Booth, E., Cronin, M., Kroese, D., Steup, D., van Ravenzwaay, B. and Hartung, T. (2014) 'Read-across approaches - misconceptions, promises and challenges ahead', ALTEX, Vol. 31, No. 4, pp.387-396.
96. Perel, P., Roberts, I. and Sena, E. et al. (2007) 'Comparison of treatment effects between animal experiments and clinical trials: systematic review', BMJ (Clinical Research Ed.), Vol. 334, No. 7586, pp.197-197, doi:10.1136/bmj.39048.407928.BE.
97. Pottenger, L.H., Bus, J.S. and Gollapudi, B.B. (2007) 'Genetic toxicity assessment: employing the best science for human safety evaluation part VI: when salt and sugar and vegetables are positive, how can genotoxicity data serve to inform risk assessment?', Toxicological Sciences, Vol. 98, pp.327-331.
98. Pound, P., Ebrahim, S., Sandercock, P., Bracken, M.B. and Roberts, I. (2004) 'Reviewing animal trials systematically (RATS) group: where is the evidence that animal research benefits humans?', BMJ (Clinical Research Ed.), Vol. 328, pp.514-517.
99. Prinz, F., Schlange, T. and Asadullah, K. (2011) 'Believe it or not: how much can we rely on published data on potential drug targets?', Nature Reviews Drug Discovery, Vol. 10, No. 9, pp.712-712.
100. Reisinger, K., Hoffmann, S., Alepée, N. et al. (2015) 'Systematic evaluation of non-animal test methods for skin sensitisation safety assessment', Toxicol. In Vitro, Vol. 29, No. 1, pp.259-270.
101. Roberts, I., Kwan, I., Evans, P. and Haig, S. (2002) 'Does animal experimentation inform human healthcare? Observations from a systematic review of international animal experiments on fluid resuscitation', BMJ: British Medical Journal, Vol. 324, pp.474-476.
102. Rojas, A., Gonzalez, I. and Figueroa, H. (2008) 'Cell line cross-contamination in biomedical research: a call to prevent unawareness', Acta Pharmacologica Sinica, Vol. 29, No. 7, pp.877-880.
103. Rottem, S. and Barile, M.F. (1993) 'Beware of mycoplasmas', Trends in Biotechnology, Vol. 11, No. 4, pp.143-151.
104. Rovida, C. and Hartung, T. (2009) 'Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t4)', ALTEX, Vol. 26, No. 4, pp.187-208.
105. Rovida, C., Asakura, C., Daneshian, M. et al. (2015) 'Toxicity testing in the 21st century beyond environmental chemicals', ALTEX, Vol. 32, No. 1, pp.25-40.
106. Rovida, C., Longo, F.F. and Rabbit, R.R. (2011) 'How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?', ALTEX, Vol. 28, No. 3, pp.273-294.
107. Russell, W.M.S. and Burch, R.L. (1959) The Principles of Humane Experimental Technique, Methuen, London, UK [online] http://altweb.jhsph.edu/pubs/books/humane-exp/het-toc (accessed 20 April 2016).
108. Scannell, J.W., Blanckley, A., Boldon, H. et al. (2012) 'Diagnosing the decline in pharmaceutical R&D efficiency', Nature Rev. Drug Discovery, Vol. 11, No. 3, pp.191-200.
109. Seaton, A. and Donaldson, K. (2005) 'Nanoscience, nanotoxicology, and the need to think small', The Lancet, Vol. 365, No. 9463, pp.923-924.
110. Seok, J., Warren, H.S. and Cuenca, A.G. et al. (2013) 'Genomic responses in mouse models poorly mimic human inflammatory diseases', Proceedings of the National Academy of Science USA, Vol. 110, No. 4, pp.3507-3512.
111. Skloot, R. (2010) The Immortal Life of Henrietta Lacks, Reprint edition, 402pp, Crown, New York.
112. Smirnova, L., Hogberg, H.T., Leist, M. and Hartung, T. (2014) 'Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities', ALTEX, Vol. 31, No. 2, pp.129-156.
113. Stacey, G.N. (2000) 'Cell contamination leads to inaccurate data: we must take action now', Nature, Vol. 203, No. 6768, p.356.
114. Steinemann, D., Göhring, G. and Schlegelberger, B. (2013) 'Genetic instability of modified stem cells - a first step towards malignant transformation?', American Journal of Stem Cells, Vol. 2, No. 1, pp.39-51.
115. Stephens, M.L., Andersen, M., Becker, R.A. et al. (2013) 'Evidence-based toxicology for the 21st century: opportunities and challenges', ALTEX, Vol. 30, No. 1, pp.74-104.
116. Tamimi, N.A.M. and Ellis, P. (2009) 'Drug development: from concept to marketing!', Nephron. Clin. Pract., Vol. 13, No. 3, pp.c125-c131.
117. van der Worp, H.B. and Macleod, M.R. (2011) 'Preclinical studies of human disease: time to take methodological quality seriously', Journal of Molecular and Cellular Cardiology, Vol. 51, No. 4, pp.449-450.
118. van der Worp, H.B., Howells, D.W. and Sena, E.S. et al. (2010) 'Can animal models of disease reliably inform human studies?', PLoS Med., Vol. 7, p.e1000245.
119. Young, L., Sung, J., Stacey, G. and Masters, J.R. (2010) 'Detection of mycoplasma in cell cultures', Nature Protocols, Vol. 5, No. 5, pp.929-934.
120. Young, N.S., Ioannidis, J.P.A. and Al-Ubaydli, O. (2008) 'Why current publication practices may distort science', PLoS Medicine, Vol. 5, No. 10, p.e201.
121. Zurlo, J. (2011) 'Evidence-based toxicology collaboration kick-off meeting', ALTEX, Vol. 28, No. 2, p.152.